NAV
Explore a selection of essential drug information below, or:
Unlock enhanced features & extensive drug insights. Create a free account.
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Danvatirsen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT
Full Drug Profiles
Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.
SUBSCRIBERECOMMENDED FOR PHARMA
Data Packages
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Generic Name
Danvatirsen
DrugBank Accession Number
DB14825
Background

Danvatirsen is under investigation in clinical trial NCT03334617 (Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy.).

Type
Biotech
Groups
Investigational
Synonyms
  • Danvatirsen
External IDs
  • AZD9150
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
31N550RD05
CAS number
1402357-06-5

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data
2Active Not RecruitingTreatmentAdvanced Colorectal Carcinoma / Advanced Non-Small Cell Lung Carcinoma / Mismatch Repair Deficient (dMMR) / Non-Small Cell Lung Carcinoma / Refractory Colorectal Carcinoma / Refractory Lung Carcinoma / Refractory Pancreatic Carcinoma / Stage II Pancreatic Cancer AJCC v8 / Stage III Colorectal Cancer AJCC v8 / Stage III Lung Cancer AJCC v8 / Stage III Pancreatic Cancer AJCC v8 / Stage IIIA Colorectal Cancer AJCC v8 / Stage IIIA Lung Cancer AJCC v8 / Stage IIIB Colorectal Cancer AJCC v8 / Stage IIIB Lung Cancer AJCC v8 / Stage IIIC Colorectal Cancer AJCC v8 / Stage IIIC Lung Cancer AJCC v8 / Stage IV Colorectal Cancer AJCC v8 / Stage IV Lung Cancer AJCC v8 / Stage IV Pancreatic Cancer AJCC v8 / Stage IVA Colorectal Cancer AJCC v8 / Stage IVA Lung Cancer AJCC v8 / Stage IVB Colorectal Cancer AJCC v8 / Stage IVB Lung Cancer AJCC v8 / Stage IVC Colorectal Cancer AJCC v81somestatusstop reasonjust information to hide
2Active Not RecruitingTreatmentNon-Small Cell Lung Cancer (NSCLC)1somestatusstop reasonjust information to hide
2CompletedTreatmentEarly Stage / Non-Small Cell Lung Cancer (NSCLC) / Resectable1somestatusstop reasonjust information to hide
2RecruitingTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)1somestatusstop reasonjust information to hide
2TerminatedTreatmentAscites / Gastrointestinal Tract Cancer / Neoplasms, Gastrointestinal / Ovarian Cancer / Ovarian Neoplasms1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at May 20, 2019 14:29 / Updated at February 21, 2021 18:54